Alcoholic Hepatitis Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Durect Corporation, Novartis, Intercept Pharmaceuticals, Immuron Ltd., Gilead Sciences

DelveInsight's "Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Alcoholic Hepatitis, historical and forecasted epidemiology as well as the Alcoholic Hepatitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Alcoholic Hepatitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alcoholic Hepatitis Market Forecast
https://www.delveinsight.com/sample-request/alcoholic-hepatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Alcoholic Hepatitis Market Report:
• The Alcoholic Hepatitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Using the State Inpatient Databases from Florida, Massachusetts, New York, and Washington from 2010 to 2014, Doshi et al. (2020) carried out a retrospective cohort analysis. Patients hospitalised with AH and aged 20 to 79 were included in the research. The bulk of the 56,973 distinct people with AH were male (39,702; 69.7%)
• In June 2023, The biopharmaceutical firm DURECT Corporation (Nasdaq: DRRX), which is researching larsucosterol for the treatment of patients with severe alcohol-associated hepatitis (AH) and reached its enrollment goal of 300 patients, today announced that enrollment in its Phase 2b AHFIRM clinical trial (NCT04563026), which is evaluating larsucosterol for the treatment of patients with acute organ injuries and chronic liver diseases, has been completed
• Key Alcoholic Hepatitis Companies: Durect Corporation, Novartis, Intercept Pharmaceuticals, Immuron Ltd., Gilead Sciences, PharmaKing, Hoffmann-La Roche, Promethera Therapeutics, and others
• Key Alcoholic Hepatitis Therapies: DUR-928, Canakinumab, INT-787, IMM 124-E, Selonsertib, MG-1, MG-2, Orlistat (Xenical), HepaStem, and others
• The Alcoholic Hepatitis epidemiology based on gender analyzed that there are more cases for Alcoholic Hepatitis in males than females
• The Alcoholic Hepatitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Alcoholic Hepatitis pipeline products will significantly revolutionize the Alcoholic Hepatitis market dynamics.

Alcoholic Hepatitis Overview
Alcoholic hepatitis (AH), as the name implies, is an inflammation of the liver brought on by excessive alcohol consumption. Patients frequently have a history of daily alcohol consumption of 8 to 10 drinks. It is typically present in conjunction with fatty liver, an early stage of alcoholic liver disease, and it may aid in the development of cirrhosis by promoting the advancement of fibrosis.

Get a Free sample for the Alcoholic Hepatitis Market Report
https://www.delveinsight.com/report-store/alcoholic-hepatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Alcoholic Hepatitis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Alcoholic Hepatitis Epidemiology Segmentation:
The Alcoholic Hepatitis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Alcoholic Hepatitis
• Prevalent Cases of Alcoholic Hepatitis by severity
• Gender-specific Prevalence of Alcoholic Hepatitis
• Diagnosed Cases of Episodic and Chronic Alcoholic Hepatitis

Download the report to understand which factors are driving Alcoholic Hepatitis epidemiology trends @ Alcoholic Hepatitis Epidemiology Forecast
https://www.delveinsight.com/sample-request/alcoholic-hepatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Alcoholic Hepatitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Alcoholic Hepatitis market or expected to get launched during the study period. The analysis covers Alcoholic Hepatitis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Alcoholic Hepatitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Alcoholic Hepatitis Therapies and Key Companies
• DUR-928: Durect Corporation
• Canakinumab: Novartis
• INT-787: Intercept Pharmaceuticals
• IMM 124-E: Immuron Ltd.
• Selonsertib: Gilead Sciences
• MG-1, MG-2: PharmaKing
• Orlistat (Xenical): Hoffmann-La Roche
• HepaStem: Promethera Therapeutics

Discover more about therapies set to grab major Alcoholic Hepatitis market share @ Alcoholic Hepatitis Treatment Market
https://www.delveinsight.com/sample-request/alcoholic-hepatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Scope of the Alcoholic Hepatitis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Alcoholic Hepatitis Companies: Durect Corporation, Novartis, Intercept Pharmaceuticals, Immuron Ltd., Gilead Sciences, PharmaKing, Hoffmann-La Roche, Promethera Therapeutics, and others
• Key Alcoholic Hepatitis Therapies: DUR-928, Canakinumab, INT-787, IMM 124-E, Selonsertib, MG-1, MG-2, Orlistat (Xenical), HepaStem, and others
• Alcoholic Hepatitis Therapeutic Assessment: Alcoholic Hepatitis current marketed and Alcoholic Hepatitis emerging therapies
• Alcoholic Hepatitis Market Dynamics: Alcoholic Hepatitis market drivers and Alcoholic Hepatitis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Alcoholic Hepatitis Unmet Needs, KOL's views, Analyst's views, Alcoholic Hepatitis Market Access and Reimbursement

To know more about Alcoholic Hepatitis companies working in the treatment market, visit @ Alcoholic Hepatitis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/alcoholic-hepatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Alcoholic Hepatitis Market Report Introduction
2. Executive Summary for Alcoholic Hepatitis
3. SWOT analysis of Alcoholic Hepatitis
4. Alcoholic Hepatitis Patient Share (%) Overview at a Glance
5. Alcoholic Hepatitis Market Overview at a Glance
6. Alcoholic Hepatitis Disease Background and Overview
7. Alcoholic Hepatitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Alcoholic Hepatitis
9. Alcoholic Hepatitis Current Treatment and Medical Practices
10. Alcoholic Hepatitis Unmet Needs
11. Alcoholic Hepatitis Emerging Therapies
12. Alcoholic Hepatitis Market Outlook
13. Country-Wise Alcoholic Hepatitis Market Analysis (2019-2032)
14. Alcoholic Hepatitis Market Access and Reimbursement of Therapies
15. Alcoholic Hepatitis Market Drivers
16. Alcoholic Hepatitis Market Barriers
17. Alcoholic Hepatitis Appendix
18. Alcoholic Hepatitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Alcoholic Hepatitis Pipeline https://www.delveinsight.com/report-store/alcoholic-hepatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Alcoholic Hepatitis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Alcoholic Hepatitis market. A detailed picture of the Alcoholic Hepatitis pipeline landscape is provided, which includes the disease overview and Alcoholic Hepatitis treatment guidelines.
Alcoholic Hepatitis Epidemiology https://www.delveinsight.com/report-store/alcoholic-hepatitis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Alcoholic Hepatitis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Alcoholic Hepatitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight

Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.